Post‐diagnosis alcohol intake and prostate cancer survival: A population‐based cohort study

Alcohol consumption has been declared a Group 1 carcinogen by the International Agency for Research on Cancer (IARC) and is a potential risk factor for several types of cancer mortality. However, evidence for an association with prostate cancer survival remains inconsistent. We examined how alcohol...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of cancer 2018-07, Vol.143 (2), p.253-262
Hauptverfasser: Farris, Megan S., Courneya, Kerry S., Kopciuk, Karen A., McGregor, S. Elizabeth, Friedenreich, Christine M.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 262
container_issue 2
container_start_page 253
container_title International journal of cancer
container_volume 143
creator Farris, Megan S.
Courneya, Kerry S.
Kopciuk, Karen A.
McGregor, S. Elizabeth
Friedenreich, Christine M.
description Alcohol consumption has been declared a Group 1 carcinogen by the International Agency for Research on Cancer (IARC) and is a potential risk factor for several types of cancer mortality. However, evidence for an association with prostate cancer survival remains inconsistent. We examined how alcohol consumption post‐diagnosis was associated with survival after prostate cancer diagnosis. Men diagnosed with prostate cancer (n = 829) in Alberta, Canada between the years 1997 and 2000 were recruited into a population‐based case–control study and then followed for up to 19 years for survival outcomes. Pre‐ and post‐diagnosis alcohol consumption, clinical characteristics and lifestyle factors were collected through in‐person interviews shortly after diagnosis and again 2–3 years post‐diagnosis. Cox proportional hazards were used to examine how post‐diagnosis alcohol consumption was associated with all‐cause and prostate cancer‐specific mortality (competing risk analysis too), in addition to first recurrence/progression or new primary cancer. Most participants reported drinking alcohol (≥once a month for 6 months) post‐diagnosis (n = 589, 71.0%). Exceeding Canadian Cancer Society (CCS) alcohol consumption recommendations (≥2 drinks/day) post‐diagnosis was associated with prostate cancer‐specific mortality relative to non‐drinkers (aHR: 1.82, 95% CI: 1.07–3.10) with borderline evidence of a linear trend. Interestingly, those in the highest quartile of drinks/week pre‐ and post‐diagnosis also had a twofold increase for prostate‐specific mortality (aHR: 2.67, 95% CI: 1.28–5.56) while controlling for competing risks. Our results support post‐diagnosis alcohol consumption was associated with increased mortality after prostate cancer diagnosis, specifically for prostate cancer‐related death. Future studies focused on confirming this burden of disease are warranted. What's new? Drinking alcohol can increase the risk of developing cancer. But after diagnosis, what does it do? Here, the authors looked for a correlation between alcohol consumption and mortality after prostate cancer diagnosis. They interviewed prostate cancer patients immediately after diagnosis and again 2‐3 years later, to record their alcohol habits before and after cancer, disease characteristics, and other lifestyle factors. Mortality data were collected for up to 19 years. Compared with non‐drinkers, they found, men who imbibed more than 8 drinks weekly had higher mortality, and those in the highest q
doi_str_mv 10.1002/ijc.31307
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2047411469</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2047411469</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3887-da5ab8de19c85ca4bf6c72dfe348c0ea86ad80aaaae39ab5e50019a93e44ed603</originalsourceid><addsrcrecordid>eNp1kLtOwzAUhi0EoqUw8ALIEhNDWjt2bmxVxaWoEgwwWye2Ay5pEuykqBuPwDPyJLiksHEWD-fzZ_8_QqeUjCkh4cQs5ZhRRpI9NKQkSwIS0mgfDf2OBAll8QAdObckhNKI8EM0CDPOoiyJh0g81K79-vhUBp6r2hmHoZT1S11iU7XwqjFUCjfWQ9BqLKGS2mLX2bVZQ3mJp7ipm66E1tSVt-TgtMLb-7bFru3U5hgdFFA6fbI7R-jp-upxdhss7m_ms-kikCxNk0BBBHmqNM1kGkngeRHLJFSFZjyVREMag0oJ-NEsgzzSkQ-TQcY051rFhI3Qee_1f33rtGvFsu5s5Z8UIeEJp5THmacuekr6RM7qQjTWrMBuBCViW6XwVYqfKj17tjN2-UqrP_K3Ow9MeuDdlHrzv0nM72a98htj5oEi</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2047411469</pqid></control><display><type>article</type><title>Post‐diagnosis alcohol intake and prostate cancer survival: A population‐based cohort study</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Farris, Megan S. ; Courneya, Kerry S. ; Kopciuk, Karen A. ; McGregor, S. Elizabeth ; Friedenreich, Christine M.</creator><creatorcontrib>Farris, Megan S. ; Courneya, Kerry S. ; Kopciuk, Karen A. ; McGregor, S. Elizabeth ; Friedenreich, Christine M.</creatorcontrib><description>Alcohol consumption has been declared a Group 1 carcinogen by the International Agency for Research on Cancer (IARC) and is a potential risk factor for several types of cancer mortality. However, evidence for an association with prostate cancer survival remains inconsistent. We examined how alcohol consumption post‐diagnosis was associated with survival after prostate cancer diagnosis. Men diagnosed with prostate cancer (n = 829) in Alberta, Canada between the years 1997 and 2000 were recruited into a population‐based case–control study and then followed for up to 19 years for survival outcomes. Pre‐ and post‐diagnosis alcohol consumption, clinical characteristics and lifestyle factors were collected through in‐person interviews shortly after diagnosis and again 2–3 years post‐diagnosis. Cox proportional hazards were used to examine how post‐diagnosis alcohol consumption was associated with all‐cause and prostate cancer‐specific mortality (competing risk analysis too), in addition to first recurrence/progression or new primary cancer. Most participants reported drinking alcohol (≥once a month for 6 months) post‐diagnosis (n = 589, 71.0%). Exceeding Canadian Cancer Society (CCS) alcohol consumption recommendations (≥2 drinks/day) post‐diagnosis was associated with prostate cancer‐specific mortality relative to non‐drinkers (aHR: 1.82, 95% CI: 1.07–3.10) with borderline evidence of a linear trend. Interestingly, those in the highest quartile of drinks/week pre‐ and post‐diagnosis also had a twofold increase for prostate‐specific mortality (aHR: 2.67, 95% CI: 1.28–5.56) while controlling for competing risks. Our results support post‐diagnosis alcohol consumption was associated with increased mortality after prostate cancer diagnosis, specifically for prostate cancer‐related death. Future studies focused on confirming this burden of disease are warranted. What's new? Drinking alcohol can increase the risk of developing cancer. But after diagnosis, what does it do? Here, the authors looked for a correlation between alcohol consumption and mortality after prostate cancer diagnosis. They interviewed prostate cancer patients immediately after diagnosis and again 2‐3 years later, to record their alcohol habits before and after cancer, disease characteristics, and other lifestyle factors. Mortality data were collected for up to 19 years. Compared with non‐drinkers, they found, men who imbibed more than 8 drinks weekly had higher mortality, and those in the highest quartile of alcohol consumption showed the biggest effect.</description><identifier>ISSN: 0020-7136</identifier><identifier>EISSN: 1097-0215</identifier><identifier>DOI: 10.1002/ijc.31307</identifier><identifier>PMID: 29435976</identifier><language>eng</language><publisher>United States: Wiley Subscription Services, Inc</publisher><subject>Aged ; Alcohol ; Alcohol Drinking - adverse effects ; Alcohol Drinking - mortality ; Alcohol use ; Alcoholic beverages ; Alcohols ; Canada - epidemiology ; Cancer ; Carcinogens ; Case-Control Studies ; Cohort analysis ; Cohort Studies ; Diagnosis ; Drinking behavior ; Health risk assessment ; Health risks ; Humans ; Life Style ; Male ; Medical diagnosis ; Medical research ; Middle Aged ; Mortality ; Population studies ; Population-based studies ; Proportional Hazards Models ; Prostate cancer ; Prostatic Neoplasms - diagnosis ; Prostatic Neoplasms - mortality ; Risk analysis ; Risk Factors ; Survival</subject><ispartof>International journal of cancer, 2018-07, Vol.143 (2), p.253-262</ispartof><rights>2018 UICC</rights><rights>2018 UICC.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3887-da5ab8de19c85ca4bf6c72dfe348c0ea86ad80aaaae39ab5e50019a93e44ed603</citedby><cites>FETCH-LOGICAL-c3887-da5ab8de19c85ca4bf6c72dfe348c0ea86ad80aaaae39ab5e50019a93e44ed603</cites><orcidid>0000-0002-4783-1966</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fijc.31307$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fijc.31307$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29435976$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Farris, Megan S.</creatorcontrib><creatorcontrib>Courneya, Kerry S.</creatorcontrib><creatorcontrib>Kopciuk, Karen A.</creatorcontrib><creatorcontrib>McGregor, S. Elizabeth</creatorcontrib><creatorcontrib>Friedenreich, Christine M.</creatorcontrib><title>Post‐diagnosis alcohol intake and prostate cancer survival: A population‐based cohort study</title><title>International journal of cancer</title><addtitle>Int J Cancer</addtitle><description>Alcohol consumption has been declared a Group 1 carcinogen by the International Agency for Research on Cancer (IARC) and is a potential risk factor for several types of cancer mortality. However, evidence for an association with prostate cancer survival remains inconsistent. We examined how alcohol consumption post‐diagnosis was associated with survival after prostate cancer diagnosis. Men diagnosed with prostate cancer (n = 829) in Alberta, Canada between the years 1997 and 2000 were recruited into a population‐based case–control study and then followed for up to 19 years for survival outcomes. Pre‐ and post‐diagnosis alcohol consumption, clinical characteristics and lifestyle factors were collected through in‐person interviews shortly after diagnosis and again 2–3 years post‐diagnosis. Cox proportional hazards were used to examine how post‐diagnosis alcohol consumption was associated with all‐cause and prostate cancer‐specific mortality (competing risk analysis too), in addition to first recurrence/progression or new primary cancer. Most participants reported drinking alcohol (≥once a month for 6 months) post‐diagnosis (n = 589, 71.0%). Exceeding Canadian Cancer Society (CCS) alcohol consumption recommendations (≥2 drinks/day) post‐diagnosis was associated with prostate cancer‐specific mortality relative to non‐drinkers (aHR: 1.82, 95% CI: 1.07–3.10) with borderline evidence of a linear trend. Interestingly, those in the highest quartile of drinks/week pre‐ and post‐diagnosis also had a twofold increase for prostate‐specific mortality (aHR: 2.67, 95% CI: 1.28–5.56) while controlling for competing risks. Our results support post‐diagnosis alcohol consumption was associated with increased mortality after prostate cancer diagnosis, specifically for prostate cancer‐related death. Future studies focused on confirming this burden of disease are warranted. What's new? Drinking alcohol can increase the risk of developing cancer. But after diagnosis, what does it do? Here, the authors looked for a correlation between alcohol consumption and mortality after prostate cancer diagnosis. They interviewed prostate cancer patients immediately after diagnosis and again 2‐3 years later, to record their alcohol habits before and after cancer, disease characteristics, and other lifestyle factors. Mortality data were collected for up to 19 years. Compared with non‐drinkers, they found, men who imbibed more than 8 drinks weekly had higher mortality, and those in the highest quartile of alcohol consumption showed the biggest effect.</description><subject>Aged</subject><subject>Alcohol</subject><subject>Alcohol Drinking - adverse effects</subject><subject>Alcohol Drinking - mortality</subject><subject>Alcohol use</subject><subject>Alcoholic beverages</subject><subject>Alcohols</subject><subject>Canada - epidemiology</subject><subject>Cancer</subject><subject>Carcinogens</subject><subject>Case-Control Studies</subject><subject>Cohort analysis</subject><subject>Cohort Studies</subject><subject>Diagnosis</subject><subject>Drinking behavior</subject><subject>Health risk assessment</subject><subject>Health risks</subject><subject>Humans</subject><subject>Life Style</subject><subject>Male</subject><subject>Medical diagnosis</subject><subject>Medical research</subject><subject>Middle Aged</subject><subject>Mortality</subject><subject>Population studies</subject><subject>Population-based studies</subject><subject>Proportional Hazards Models</subject><subject>Prostate cancer</subject><subject>Prostatic Neoplasms - diagnosis</subject><subject>Prostatic Neoplasms - mortality</subject><subject>Risk analysis</subject><subject>Risk Factors</subject><subject>Survival</subject><issn>0020-7136</issn><issn>1097-0215</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kLtOwzAUhi0EoqUw8ALIEhNDWjt2bmxVxaWoEgwwWye2Ay5pEuykqBuPwDPyJLiksHEWD-fzZ_8_QqeUjCkh4cQs5ZhRRpI9NKQkSwIS0mgfDf2OBAll8QAdObckhNKI8EM0CDPOoiyJh0g81K79-vhUBp6r2hmHoZT1S11iU7XwqjFUCjfWQ9BqLKGS2mLX2bVZQ3mJp7ipm66E1tSVt-TgtMLb-7bFru3U5hgdFFA6fbI7R-jp-upxdhss7m_ms-kikCxNk0BBBHmqNM1kGkngeRHLJFSFZjyVREMag0oJ-NEsgzzSkQ-TQcY051rFhI3Qee_1f33rtGvFsu5s5Z8UIeEJp5THmacuekr6RM7qQjTWrMBuBCViW6XwVYqfKj17tjN2-UqrP_K3Ow9MeuDdlHrzv0nM72a98htj5oEi</recordid><startdate>20180715</startdate><enddate>20180715</enddate><creator>Farris, Megan S.</creator><creator>Courneya, Kerry S.</creator><creator>Kopciuk, Karen A.</creator><creator>McGregor, S. Elizabeth</creator><creator>Friedenreich, Christine M.</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TO</scope><scope>7U9</scope><scope>H94</scope><scope>K9.</scope><orcidid>https://orcid.org/0000-0002-4783-1966</orcidid></search><sort><creationdate>20180715</creationdate><title>Post‐diagnosis alcohol intake and prostate cancer survival: A population‐based cohort study</title><author>Farris, Megan S. ; Courneya, Kerry S. ; Kopciuk, Karen A. ; McGregor, S. Elizabeth ; Friedenreich, Christine M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3887-da5ab8de19c85ca4bf6c72dfe348c0ea86ad80aaaae39ab5e50019a93e44ed603</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Aged</topic><topic>Alcohol</topic><topic>Alcohol Drinking - adverse effects</topic><topic>Alcohol Drinking - mortality</topic><topic>Alcohol use</topic><topic>Alcoholic beverages</topic><topic>Alcohols</topic><topic>Canada - epidemiology</topic><topic>Cancer</topic><topic>Carcinogens</topic><topic>Case-Control Studies</topic><topic>Cohort analysis</topic><topic>Cohort Studies</topic><topic>Diagnosis</topic><topic>Drinking behavior</topic><topic>Health risk assessment</topic><topic>Health risks</topic><topic>Humans</topic><topic>Life Style</topic><topic>Male</topic><topic>Medical diagnosis</topic><topic>Medical research</topic><topic>Middle Aged</topic><topic>Mortality</topic><topic>Population studies</topic><topic>Population-based studies</topic><topic>Proportional Hazards Models</topic><topic>Prostate cancer</topic><topic>Prostatic Neoplasms - diagnosis</topic><topic>Prostatic Neoplasms - mortality</topic><topic>Risk analysis</topic><topic>Risk Factors</topic><topic>Survival</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Farris, Megan S.</creatorcontrib><creatorcontrib>Courneya, Kerry S.</creatorcontrib><creatorcontrib>Kopciuk, Karen A.</creatorcontrib><creatorcontrib>McGregor, S. Elizabeth</creatorcontrib><creatorcontrib>Friedenreich, Christine M.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><jtitle>International journal of cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Farris, Megan S.</au><au>Courneya, Kerry S.</au><au>Kopciuk, Karen A.</au><au>McGregor, S. Elizabeth</au><au>Friedenreich, Christine M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Post‐diagnosis alcohol intake and prostate cancer survival: A population‐based cohort study</atitle><jtitle>International journal of cancer</jtitle><addtitle>Int J Cancer</addtitle><date>2018-07-15</date><risdate>2018</risdate><volume>143</volume><issue>2</issue><spage>253</spage><epage>262</epage><pages>253-262</pages><issn>0020-7136</issn><eissn>1097-0215</eissn><abstract>Alcohol consumption has been declared a Group 1 carcinogen by the International Agency for Research on Cancer (IARC) and is a potential risk factor for several types of cancer mortality. However, evidence for an association with prostate cancer survival remains inconsistent. We examined how alcohol consumption post‐diagnosis was associated with survival after prostate cancer diagnosis. Men diagnosed with prostate cancer (n = 829) in Alberta, Canada between the years 1997 and 2000 were recruited into a population‐based case–control study and then followed for up to 19 years for survival outcomes. Pre‐ and post‐diagnosis alcohol consumption, clinical characteristics and lifestyle factors were collected through in‐person interviews shortly after diagnosis and again 2–3 years post‐diagnosis. Cox proportional hazards were used to examine how post‐diagnosis alcohol consumption was associated with all‐cause and prostate cancer‐specific mortality (competing risk analysis too), in addition to first recurrence/progression or new primary cancer. Most participants reported drinking alcohol (≥once a month for 6 months) post‐diagnosis (n = 589, 71.0%). Exceeding Canadian Cancer Society (CCS) alcohol consumption recommendations (≥2 drinks/day) post‐diagnosis was associated with prostate cancer‐specific mortality relative to non‐drinkers (aHR: 1.82, 95% CI: 1.07–3.10) with borderline evidence of a linear trend. Interestingly, those in the highest quartile of drinks/week pre‐ and post‐diagnosis also had a twofold increase for prostate‐specific mortality (aHR: 2.67, 95% CI: 1.28–5.56) while controlling for competing risks. Our results support post‐diagnosis alcohol consumption was associated with increased mortality after prostate cancer diagnosis, specifically for prostate cancer‐related death. Future studies focused on confirming this burden of disease are warranted. What's new? Drinking alcohol can increase the risk of developing cancer. But after diagnosis, what does it do? Here, the authors looked for a correlation between alcohol consumption and mortality after prostate cancer diagnosis. They interviewed prostate cancer patients immediately after diagnosis and again 2‐3 years later, to record their alcohol habits before and after cancer, disease characteristics, and other lifestyle factors. Mortality data were collected for up to 19 years. Compared with non‐drinkers, they found, men who imbibed more than 8 drinks weekly had higher mortality, and those in the highest quartile of alcohol consumption showed the biggest effect.</abstract><cop>United States</cop><pub>Wiley Subscription Services, Inc</pub><pmid>29435976</pmid><doi>10.1002/ijc.31307</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0002-4783-1966</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0020-7136
ispartof International journal of cancer, 2018-07, Vol.143 (2), p.253-262
issn 0020-7136
1097-0215
language eng
recordid cdi_proquest_journals_2047411469
source MEDLINE; Access via Wiley Online Library; EZB-FREE-00999 freely available EZB journals
subjects Aged
Alcohol
Alcohol Drinking - adverse effects
Alcohol Drinking - mortality
Alcohol use
Alcoholic beverages
Alcohols
Canada - epidemiology
Cancer
Carcinogens
Case-Control Studies
Cohort analysis
Cohort Studies
Diagnosis
Drinking behavior
Health risk assessment
Health risks
Humans
Life Style
Male
Medical diagnosis
Medical research
Middle Aged
Mortality
Population studies
Population-based studies
Proportional Hazards Models
Prostate cancer
Prostatic Neoplasms - diagnosis
Prostatic Neoplasms - mortality
Risk analysis
Risk Factors
Survival
title Post‐diagnosis alcohol intake and prostate cancer survival: A population‐based cohort study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-21T09%3A07%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Post%E2%80%90diagnosis%20alcohol%20intake%20and%20prostate%20cancer%20survival:%20A%20population%E2%80%90based%20cohort%20study&rft.jtitle=International%20journal%20of%20cancer&rft.au=Farris,%20Megan%20S.&rft.date=2018-07-15&rft.volume=143&rft.issue=2&rft.spage=253&rft.epage=262&rft.pages=253-262&rft.issn=0020-7136&rft.eissn=1097-0215&rft_id=info:doi/10.1002/ijc.31307&rft_dat=%3Cproquest_cross%3E2047411469%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2047411469&rft_id=info:pmid/29435976&rfr_iscdi=true